318 related articles for article (PubMed ID: 37006997)
1. Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment.
Kaurav M; Ruhi S; Al-Goshae HA; Jeppu AK; Ramachandran D; Sahu RK; Sarkar AK; Khan J; Ashif Ikbal AM
Front Pharmacol; 2023; 14():1159131. PubMed ID: 37006997
[TBL] [Abstract][Full Text] [Related]
2. Dendrimer-mediated approaches for the treatment of brain tumor.
Dwivedi N; Shah J; Mishra V; Mohd Amin MC; Iyer AK; Tekade RK; Kesharwani P
J Biomater Sci Polym Ed; 2016; 27(7):557-80. PubMed ID: 26928261
[TBL] [Abstract][Full Text] [Related]
3. Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme.
Sahoo RK; Gupta T; Batheja S; Goyal AK; Gupta U
Curr Drug Metab; 2022; 23(9):708-722. PubMed ID: 35713127
[TBL] [Abstract][Full Text] [Related]
4. Surface-Modified G4 PAMAM Dendrimers Cross the Blood-Brain Barrier Following Multiple Tail-Vein Injections in C57BL/6J Mice.
Srinageshwar B; Dils A; Sturgis J; Wedster A; Kathirvelu B; Baiyasi S; Swanson D; Sharma A; Dunbar GL; Rossignol J
ACS Chem Neurosci; 2019 Sep; 10(9):4145-4150. PubMed ID: 31390175
[TBL] [Abstract][Full Text] [Related]
5. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
[TBL] [Abstract][Full Text] [Related]
6. PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia.
Santos SD; Xavier M; Leite DM; Moreira DA; Custódio B; Torrado M; Castro R; Leiro V; Rodrigues J; Tomás H; Pêgo AP
J Control Release; 2018 Dec; 291():65-79. PubMed ID: 30308255
[TBL] [Abstract][Full Text] [Related]
7. Dendrimer technologies for brain tumor.
Mishra V; Kesharwani P
Drug Discov Today; 2016 May; 21(5):766-78. PubMed ID: 26891979
[TBL] [Abstract][Full Text] [Related]
8. Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.
Zhang F; Mastorakos P; Mishra MK; Mangraviti A; Hwang L; Zhou J; Hanes J; Brem H; Olivi A; Tyler B; Kannan RM
Biomaterials; 2015 Jun; 52():507-16. PubMed ID: 25818456
[TBL] [Abstract][Full Text] [Related]
9. A novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer.
Han S; Zheng H; Lu Y; Sun Y; Huang A; Fei W; Shi X; Xu X; Li J; Li F
J Drug Target; 2018 Jan; 26(1):86-94. PubMed ID: 28635335
[TBL] [Abstract][Full Text] [Related]
10. Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier.
Hemmer R; Hall A; Spaulding R; Rossow B; Hester M; Caroway M; Haskamp A; Wall S; Bullen HA; Morris C; Haik KL
Molecules; 2013 Sep; 18(9):11537-52. PubMed ID: 24048286
[TBL] [Abstract][Full Text] [Related]
11. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
12.
Wei X; Liu Z; Zhao Z
Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
[TBL] [Abstract][Full Text] [Related]
13. PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy.
Surekha B; Kommana NS; Dubey SK; Kumar AVP; Shukla R; Kesharwani P
Colloids Surf B Biointerfaces; 2021 Aug; 204():111837. PubMed ID: 33992888
[TBL] [Abstract][Full Text] [Related]
14. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
16. Dendrimers: Patents for Alzheimer's Disease.
Maheshwari S; Singh A
Recent Pat Nanotechnol; 2023 Oct; ():. PubMed ID: 37904560
[TBL] [Abstract][Full Text] [Related]
17. [Preparation and
Huang AH; Han SP; Lu YP; Ma R; Zheng HS; Li FZ
Zhongguo Zhong Yao Za Zhi; 2018 Apr; 43(8):1618-1625. PubMed ID: 29751708
[TBL] [Abstract][Full Text] [Related]
18. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
[TBL] [Abstract][Full Text] [Related]
19. PAMAM Dendrimers Cross the Blood-Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice.
Srinageshwar B; Peruzzaro S; Andrews M; Johnson K; Hietpas A; Clark B; McGuire C; Petersen E; Kippe J; Stewart A; Lossia O; Al-Gharaibeh A; Antcliff A; Culver R; Swanson D; Dunbar G; Sharma A; Rossignol J
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335421
[TBL] [Abstract][Full Text] [Related]
20. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.
Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U
Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
